Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Lucia Silva-Fernandez, Diederik Decock, Mark Lunt, Audrey Low, Kath Watson, BSRBR-RA Contributors Group, Deborah Symmons, Kimme Hyrich

Research output: Contribution to journalArticlepeer-review


Search results